Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine

scientific article

Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NRD.2016.234
P932PMC publication ID5443656
P698PubMed publication ID27885282

P50authorMichiaki KuboQ42316443
Richard WeinshilboumQ52447985
Mark J RatainQ87725760
P2093author name stringKathleen M Giacomini
Taisei Mushiroda
Sook Wah Yee
P2860cites workClinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 updateQ24567766
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patientsQ34215820
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.Q34345953
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimensQ34375569
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopeniaQ34433052
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.Q37107608
Human leukocyte antigen-associated drug hypersensitivityQ38058954
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.Q39920642
Genetic variants associated with phenytoin-related severe cutaneous adverse reactionsQ46788949
Massive schizophrenia genomics study offers new drug directionsQ87602053
P433issue1
P921main subjectgenome-wide association studyQ1098876
P304page(s)1
P577publication date2016-11-25
P1433published inNature Reviews Drug DiscoveryQ45998
P1476titleGenome-wide association studies of drug response and toxicity: an opportunity for genome medicine
P478volume16

Reverse relations

cites work (P2860)
Q57135523A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate
Q93243749A scientist engineer's contribution to therapeutic discovery and development
Q57557226Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population
Q91865303Benefits and limitations of genome-wide association studies
Q47377237Biomarkers: Delivering on the expectation of molecularly driven, quantitative health
Q55208199CATCH-KB: Establishing a Pharmacogenomics Variant Repository for Chemotherapy-Induced Cardiotoxicity.
Q38370270Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions
Q54983009Exploring the Potential of Direct-To-Consumer Genomic Test Data for Predicting Adverse Drug Events.
Q50123812Full genetic analysis for genome-wide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine.
Q90916419HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project
Q52431756Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective from the International Transporter Consortium.
Q58769239Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
Q92555536Personalized Medicine and the Power of Electronic Health Records
Q91616137Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell
Q90470606Screening of Genetic Factor in the Interaction Between Periodontitis and Metabolic Traits Using Candidate Gene Association Study (CGAS)
Q47355032The RA-MAP Consortium: a working model for academia-industry collaboration.
Q87954788The genetics of antipsychotic response in schizophrenia
Q58786509The impact of genome-wide association studies on biomedical research publications
Q45943634The influence of big (clinical) data and genomics on precision medicine and drug development.
Q50199930The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants
Q64234744Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine
Q56889079Translational -omics: Future potential and current challenges in precision medicine